Hyperglycemia regulates hypoxia-inducible factor-1α protein stability and function

Diabetes

Volumn 53, Issue 12, 2004, Pages 3226-3232

  Catrina, Sergiu Bogdan ^a,b   Okamoto, Kensaku ^a   Pereira, Teresa ^a   Brismar, Kerstin ^a   Poellinger, Lorenz ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MANNITOL; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEASOME INHIBITOR; TRANSCRIPTION FACTOR;

ARTICLE; CELL HYPOXIA; CHRONIC VEIN INSUFFICIENCY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGRADATION KINETICS; DIABETES MELLITUS; DOSE RESPONSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROXYLATION; HYPERGLYCEMIA; HYPEROSMOLARITY; HYPOXIA; OXYGEN TENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN STABILITY; REGULATORY MECHANISM; SKIN FIBROBLAST; TRANSCRIPTION REGULATION;

CELL HYPOXIA; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBROBLASTS; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MANNITOL; MICROCIRCULATION; SKIN; TRANSCRIPTION FACTORS;

EID: 9444296528     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.12.3226     Document Type: Article

References (49)

1. The effect of Intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986, 1993
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837-853, 1998
3. Cameron NE, Eaton SE, Cotter MA, Tesfaye S: Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44:1973-1988, 2001
4. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den EM, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993
5. 2 sensing. Science 292:464-468, 2001
6. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ: Targeting of HIF-alpha to the von Hippel-Iindau ubiquitylation complex by unregulated prolyl hydroxylation. Science 292:468-472, 2001
7. Bruick RK, McKnight SL: A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294:1337-1340, 2001
8. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ: C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54, 2001
9. Ivan M, Haberberger T, Gervasi DC, Michelson KS, Gunzler V, Kondo K, Yang H, Sorokina I, Conaway RC, Conaway JW, Kaelin WG Jr: Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci U S A 99:13459-13464, 2002
10. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L: Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J Biol Chem 274:6519-6525, 1999
11. Huang LE, Gu J, Schau M, Bunn HF: Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95:7987-7992, 1998
12. Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B: Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1α/ARNT. EMBO J 17:5085-5094, 1998
13. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL: Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2. Cancer Res 59:3915-3918, 1999
14. Treins C, Giorgetti-Peraldi S, Murdaca J, Van Obberghen E: Regulation of vascular endothelial growth factor expression by advanced glycation end products. J Biol Chem 276:43836-43841, 2001
15. Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L: Activation of hypoxia-inducible factor 1α: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci U S A 94:5667-5672, 1997
16. Kallio PJ, Okamoto K, O'Brien S, Carrero P, Makino Y, Tanaka H, Poellinger L: Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α. EMBO J 17:6573-6586, 1998
17. Hirsila M, Koivunen P, Gunzler V, Kivirikko H, Myllyharju J: Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278:30772-30780, 2003
18. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH, Yoo MA, Song EJ, Lee KJ, Kim KW: Regulation and destabilization of HIF-1α by ARD1-mediated acetylation. Cell 111:709-720, 2002
19. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kajstura J: Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50:2363-2375, 2001
20. Chen D, Li M, Luo J, Gu W: Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem 278:13595-13598, 2003
21. Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA: Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci 37:886-897, 1996
22. Newrick PG, Wilson AJ, Jakubowski J, Boulton AJ, Ward JD: Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed) 293:1053-1054, 1986
23. Santilli SM, Fiegel VD, Knighton DR: Alloxan diabetes alters the rabbit transarterial wall oxygen gradient. J Vasc Surg 18:227-233, 1993
24. Melin J, Hellberg O, Akyurek LM, Kallskog O, Larsson E, Fellstrom BC: Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int 52:985-991, 1997
25. Kalani M, Brismar K, Fagrell B, Ostergren J, Jorneskog G: Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care 22:147-151, 1999
26. Malmberg K, Norhammar A, Wedel H, Ryden L: Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626-2632, 1999
27. Fernandez-Real JM, Lopez-Bermejo A, Ricart W: Cross-talk between iron metabolism and diabetes. Diabetes 51:2348-2354, 2002
28. Blagosklonny MV: Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors. Oncogene 20:395-398, 2001
29. Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F, Neckers LM: Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. J Biol Chem 277:29936-29944, 2002
30. Zhou J, Schmid T, Frank R, Brune B: PI3K/Akt is required for heat shock proteins to protect HIF-1α from pVHL-independent degradation. J Biol Chem 2004
31. Hooper PL: Diabetes, nitric oxide, and heat shock proteins (Letter). Diabetes Care 26:951-952, 2003
32. Poulaki V, Qin W, Joussen AM, Hurlbut P, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP: Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGF. J Clin Invest 109:805-815, 2002
33. Lu H, Forbes RA, Verma A: Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277:23111-23115, 2002
34. Duyndam MC, Hulscher TM, Fontjjn D, Pinedo HM, Boven E: Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1α protein by the oxidative Stressor arsenite. J Biol Chem 276:48066-48076, 2001
35. Krones A, Jungermann K, Kietzmann T: Cross-talk between the signals hypoxia and glucose at the glucose response element of the L-type pyruvate kinase gene. Endocrinology 142:2707-2718, 2001
36. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12:149-162, 1998
37. Ryan HE, Lo J, Johnson RS: HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 17:3005-3015, 1998
38. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E, Keshet E: Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485-490, 1998
39. Williams KJ, Telfer BA, Airley RE, Peters HP, Sheridan MR, van der Kogel AJ, Harris AL, Stratford IJ: A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis. Oncogene 21:282-290, 2002
40. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
41. Datta K, Li J, Bhattacharya R, Gasparian L, Wang E, Mukhopadhyay D: Protein kinase C zeta transactivates hypoxia-inducible factor alpha by promoting its association with p300 in renal cancer. Cancer Res 64:456-462, 2004
42. Temes E, Martin-Puig S, Aragones J, Jones DR, Olmos G, Merida I, Landazuri MO: Role of diacylglycerol induced by hypoxia in the regulation of HIF-1α activity. Biochem Biophys Res Commun 315:44-50, 2004
43. Minet E, Michel G, Mottet D, Raes M, Michiels C: Transduction pathways involved in hypoxia-inducible factor-1 phosphorylation and activation. Free Radic Biol Med 31:847-855, 2001
44. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
45. Haddad JJ: Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal. 14:879-897, 2002
46. Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H, Poellinger L: Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α. Mol Cell Biol 20:402-415, 2000
47. Scheid A, Wenger RH, Schaffer L, Camenisch I, Distler O, Ferenc A, Cristina H, Ryan HE, Johnson RS, Wagner KF, Stauffer UG, Bauer C, Gassmann M, Meuli M: Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-β3. FASEB J 16:411-413, 2002
48. Clyne CA, Ramsden WH, Chant AD, Webster JH: Oxygen tension on the skin of the gaiter area of limbs with venous disease. Br J Surg 72:644-647, 1985
49. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C, Gassmann M, Candinas D: HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15:2445-2453, 2001